HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification and characterization of a small inhibitory peptide that can target DNA-PKcs autophosphorylation and increase tumor radiosensitivity.

AbstractPURPOSE:
The DNA protein kinase catalytic subunit (DNA-PKcs) is one of the critical elements involved in the DNA damage repair process. Inhibition of DNA-PKcs results in hypersensitivity to ionizing radiation (IR); therefore, this approach has been explored to develop molecular targeted radiosensitizers. Here, we aimed to develop small inhibitory peptides that could specifically target DNA-PKcs autophosphorylation, a critical step for the enzymatic activation of the kinase in response to IR.
METHODS AND MATERIALS:
We generated several small fusion peptides consisting of 2 functional domains, 1 an internalization domain and the other a DNA-PKcs autophosphorylation inhibitory domain. We characterized the internalization, toxicity, and radiosensitization activities of the fusion peptides. Furthermore, we studied the mechanisms of the inhibitory peptides on DNA-PKcs autophosphorylation and DNA repair.
RESULTS:
We found that among several peptides, the biotin-labeled peptide 3 (BTW3) peptide, which targets DNA-PKcs threonine 2647 autophosphorylation, can abrogate IR-induced DNA-PKcs activation and cause prolonged γ-H2AX focus formation. We demonstrated that BTW3 exposure led to hypersensitivity to IR in DNA-PKcs-proficient cells but not in DNA-PKcs-deficient cells.
CONCLUSIONS:
The small inhibitory peptide BTW3 can specifically target DNA-PKcs autophosphorylation and enhance radiosensitivity; therefore, it can be further developed as a novel class of radiosensitizer.
AuthorsXiaonan Sun, Chunying Yang, Hai Liu, Qi Wang, Shi-Xiu Wu, Xia Li, Tian Xie, Kathryn L Brinkman, Bin S Teh, E Brian Butler, Bo Xu, Shu Zheng
JournalInternational journal of radiation oncology, biology, physics (Int J Radiat Oncol Biol Phys) Vol. 84 Issue 5 Pg. 1212-9 (Dec 01 2012) ISSN: 1879-355X [Electronic] United States
PMID22592045 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
CopyrightCopyright © 2012 Elsevier Inc. All rights reserved.
Chemical References
  • BTW3 peptide
  • H2AX protein, human
  • Histones
  • Peptides
  • Protein Kinase Inhibitors
  • Recombinant Fusion Proteins
  • Threonine
  • Biotin
  • DNA-Activated Protein Kinase
Topics
  • Amino Acid Sequence
  • Biotin (analogs & derivatives, chemical synthesis, pharmacology)
  • DNA End-Joining Repair
  • DNA-Activated Protein Kinase (antagonists & inhibitors, metabolism)
  • Drug Screening Assays, Antitumor (methods)
  • Enzyme Activation (drug effects)
  • Histones (biosynthesis)
  • Humans
  • Molecular Targeted Therapy (methods)
  • Peptides (chemical synthesis, pharmacology)
  • Phosphorylation (drug effects)
  • Protein Kinase Inhibitors (chemistry, pharmacology)
  • Radiation Tolerance (drug effects)
  • Recombinant Fusion Proteins (chemistry, pharmacology)
  • Threonine (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: